drugset / Trial / NCT01975636
An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single dose study in healthy male subjects.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-11
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elenbecestat | Small molecule | 100 mg | Oral |
Indications
No indication recorded.